Press releases
- TransMedics Reports First Quarter 2024 Financial Results
- TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- TransMedics to Present at Upcoming March Investor Conferences
- TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results
- TransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 90.08 |
---|---|
High | 90.08 |
Low | 87.24 |
Bid | 87.10 |
Offer | 89.02 |
Previous close | 88.42 |
Average volume | -- |
---|---|
Shares outstanding | 32.85m |
Free float | 31.75m |
P/E (TTM) | -- |
Market cap | 3.19bn USD |
EPS (TTM) | -0.7685 USD |
Data delayed at least 15 minutes, as of Apr 30 2024 18:31 BST.
More ▼